NARIUnknown
Inari Medical, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Inari Medical, Inc. (NARI), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are NARI insiders buying or selling?
Inari Medical, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since May 2020, Trabud has recorded 216 Form 4 filings for NARI: 13 buys ($25.9M) and 203 sells ($583.3M).
Source: SEC EDGAR Form 4
Key Statistics (May 2020 – Jan 9, 2025)
Total Form 4 filings
216
SEC EDGAR
Insider filers
12
Insider buys (13)
$25.9M
Insider sells (203)
$583.3M
Insider sentiment
Net sellingNet insider flow of $557.4M in net selling since May 2020.
Recent NARI insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jan 9, 2025 | William Hoffman | Director | Sale | 200.0K | $60.47 | $12.1M | SEC ↗ |
| Dec 21, 2024 | Andrew Hykes | President and CEO | Sale | 3.0K | $55.29 | $165.9K | SEC ↗ |
| Dec 18, 2024 | William Hoffman | Director | Sale | 60.0K | $55.66 | $3.3M | SEC ↗ |
| Dec 12, 2024 | Thomas Tu | Chief Medical Officer | Sale | 4.0K | $55.00 | $220.0K | SEC ↗ |
| Nov 22, 2024 | Andrew Hykes | President and CEO | Sale | 3.0K | $50.83 | $152.5K | SEC ↗ |
| Nov 20, 2024 | William Hoffman | Director | Sale | 60.0K | $51.16 | $3.1M | SEC ↗ |
| Oct 31, 2024 | Andrew Hykes | President and CEO | Sale | 3.0K | $50.00 | $150.0K | SEC ↗ |
| Oct 31, 2024 | William Hoffman | Director | Sale | 40.0K | $50.05 | $2.0M | SEC ↗ |
| Oct 18, 2024 | William Hoffman | Director | Sale | 40.0K | $45.02 | $1.8M | SEC ↗ |
| Sep 18, 2024 | William Hoffman | Director | Sale | 40.0K | $45.83 | $1.8M | SEC ↗ |
| Sep 13, 2024 | Mitch C. Hill, | Chief Financial Officer | Sale | 3.0K | $45.13 | $135.4K | SEC ↗ |
| Aug 22, 2024 | Andrew Hykes | President and CEO | Sale | 3.0K | $50.00 | $150.0K | SEC ↗ |
| Aug 20, 2024 | William Hoffman | Director | Sale | 60.0K | $49.36 | $3.0M | SEC ↗ |
| Aug 14, 2024 | Mitch C. Hill, | Chief Financial Officer | Sale | 5.0K | $47.99 | $240.0K | SEC ↗ |
| Jul 24, 2024 | Andrew Hykes | President and CEO | Sale | 3.0K | $55.23 | $165.7K | SEC ↗ |
| Jul 18, 2024 | William Hoffman | Director | Sale | 60.0K | $56.74 | $3.4M | SEC ↗ |
| Jul 18, 2024 | Thomas Tu | Chief Medical Officer | Sale | 3.5K | $55.16 | $192.0K | SEC ↗ |
| Jul 16, 2024 | Thomas Tu | Chief Medical Officer | Sale | 16.5K | $55.09 | $910.1K | SEC ↗ |
| Jul 16, 2024 | Mitch C. Hill, | Chief Financial Officer | Sale | 5.0K | $53.95 | $269.8K | SEC ↗ |
| Jul 3, 2024 | William Hoffman | Director | Sale | 20.0K | $50.15 | $1.0M | SEC ↗ |
| Jul 3, 2024 | Andrew Hykes | President and CEO | Sale | 3.0K | $50.08 | $150.2K | SEC ↗ |
| Jun 24, 2024 | Rebecca Chambers | Director | Sale | 260 | $45.99 | $12.0K | SEC ↗ |
| Jun 20, 2024 | William Hoffman | Director | Sale | 40.0K | $43.54 | $1.7M | SEC ↗ |
| Jun 14, 2024 | Mitch C. Hill, | Chief Financial Officer | Sale | 5.0K | $47.60 | $238.0K | SEC ↗ |
| May 31, 2024 | MILDER DONALD B | Director | Purchase | 56.1K | $53.44 | $3.0M | SEC ↗ |
Showing the 25 most recent of 216 Form 4 filings for Inari Medical, Inc..
Most active NARI insiders
- William Hoffman62 filings
- Mitch C. Hill,44 filings
- Andrew Hykes39 filings
- Thomas Tu28 filings
- MILDER DONALD B26 filings
Ask anything about NARI insider activity
Use Trabud's AI agent to query Inari Medical, Inc.'s Form 4 history in plain English — "Show me NARI CEO purchases this year" or compare it against any other ticker.
Open the AI agentNARI insider trading FAQ
Are Inari Medical, Inc. insiders buying or selling?
Inari Medical, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since May 2020, Trabud has recorded 216 Form 4 filings for NARI: 13 buys ($25.9M) and 203 sells ($583.3M). Over the full record that is net selling of $557.4M.
How many insiders trade NARI stock?
12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Inari Medical, Inc.. The most recent filing was accepted on Jan 9, 2025.
Where does Trabud get NARI insider trading data?
All NARI insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.